发明名称 INHIBITORS OF ASPARTYL PROTEASE
摘要 THE PRESENT INVENTION RELATES TO A NOVEL CLASS OF SULFONAMIDES WHICH ARE ASPARTYL PROTEASE INHIBITORS. IN ONE EMBODIMENT, THIS INVENTION RELATES TO A NOVEL CLASS OF HIV ASPARTYL PROTEASE INHIBITORS CHARACTERIZED BY SPECIFIC STRUCTURAL AND PHYSICOCHEMICAL FEATURES. THIS INVENTION ALSO RELATES TO PHARMACEUTICAL COMPOSITIONS COMPRISING THESE COMPOUNDS. THE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF THIS INVENTION ARE PARTICULARLY WELL SUITED FOR INHIBITING HIV-1 AND HIV-2 PROTEASE ACTIVITY AND CONSEQUENTLY, MAY BE ADVANTAGEOUSLY USED AS ANTI-VIRAL AGENTS AGAINST THE HIV-1 AND HIV-2 VIRUSES. THIS INVENTION ALSO RELATES TO METHODS FOR INHIBITING THE ACTIVITY OF HIV ASPARTYL PROTEASE USING THE COMPOUNDS OF THIS INVENTION AND METHODS FOR SCREENING COMPOUNDS FOR ANTI-HIV ACTIVITY.
申请公布号 MY137777(A) 申请公布日期 2009.03.31
申请号 MYPI20002595 申请日期 2000.06.08
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 MICHAEL ROBIN HALE;ISTVAN KALDOR;JOHN FRANKLIN MILLER;MICHAEL STEPHEN BRIEGER;ROGER TUNG;STEPHEN PRICE;ROBIN DAVID WILKES;WAYNE CARL SCHAIRER;ASHLEY NICHOLAS JARVIS;ANDREW SPALTENSTEIN;ERIC STEVEN FURFINE;VICENTE SAMANO
分类号 C07D317/62;A61K;A61K31/34;A61K31/343;A61K31/352;A61K31/36;A61K31/5377;A61K45/06;A61P;A61P31/12;A61P31/18;A61P43/00;C07C;C07C311/18;C07D;C07D317/46;C07D407/12;C07D493/04 主分类号 C07D317/62
代理机构 代理人
主权项
地址